Top Industry News
- Health Canada Implements ICH Guideline on Good Clinical Practice
- ANVISA has New Regulatory Model
- TGA- An Action Plan for Medical Devices
- FDA- REMS: FDA’s Application of Statutory Factors in Determining When a REMS Is Necessary
- MHRA- Guidance on Substantial Amendments to a Clinical Trial if the UK Leaves the EU with No Deal
- ICH Guideline E19 on Optimisation of Safety Data Collection
- MHRA- Updates to Packaging Components and Instructions on Submissions if the UK Leaves the EU Without a Deal for Those Marketing Authorisations (MA) Issued Following Conversion of EU MA (Updated)
Mergers & Acquisitions
- Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®.
- Merck Completes Tender Offer to Acquire Immune Design
- Johnson & Johnson Announces Completion of Acquisition of Auris Health, Inc.
- Bruker Announces Acquisition of RAVE LLC
- ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines
- Amneal Announces Agreement with Zentiva to Divest Creo Pharma
- Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio Targeting Innate Immune System